Tower Research Capital LLC (Trc) Argenx Se Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Argenx Se stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 960 shares of ARGX stock, worth $541,660. This represents 0.01% of its overall portfolio holdings.

Number of Shares

960

Previous 1,147 16.3%

Holding current value

$541,660

Previous $493,000 5.48%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$434.22 - $551.9 $81,199 - $103,205	-187 Reduced 16.3%	960 $520,000
Q2 2024 Aug 13, 2024	BUY	$356.01 - $451.55 $350,669 - $444,776	985 Added 608.02%	1,147 $493,000
Q1 2024 May 15, 2024	SELL	$356.95 - $413.29 $296,268 - $343,030	-830 Reduced 83.67%	162 $63,000
Q4 2023 Feb 13, 2024	BUY	$338.91 - $506.01 $26,773 - $39,974	79 Added 8.65%	992 $377,000
Q3 2023 Nov 14, 2023	SELL	$369.35 - $548.43 $695,486 - $1.03 Million	-1,883 Reduced 67.35%	913 $448,000
Q2 2023 Aug 14, 2023	BUY	$360.14 - $422.58 $910,433 - $1.07 Million	2,528 Added 943.28%	2,796 $1.09 Million
Q1 2023 May 09, 2023	SELL	$334.23 - $403.65 $112,969 - $136,433	-338 Reduced 55.78%	268 $100,000
Q4 2022 Feb 10, 2023	SELL	$342.17 - $402.31 $248,073 - $291,674	-725 Reduced 54.47%	606 $229,000
Q3 2022 Nov 10, 2022	SELL	$343.2 - $395.75 $168,168 - $193,917	-490 Reduced 26.91%	1,331 $469,000
Q2 2022 Aug 15, 2022	BUY	$269.58 - $378.88 $6,200 - $8,714	23 Added 1.28%	1,821 $689,000
Q1 2022 May 12, 2022	BUY	$254.45 - $351.06 $163,102 - $225,029	641 Added 55.4%	1,798 $567,000
Q4 2021 Feb 14, 2022	SELL	$272.01 - $353.03 $155,589 - $201,933	-572 Reduced 33.08%	1,157 $405,000
Q3 2021 Nov 15, 2021	SELL	$295.0 - $350.58 $533,065 - $633,498	-1,807 Reduced 51.1%	1,729 $522,000
Q2 2021 Aug 16, 2021	BUY	$257.11 - $319.92 $764,130 - $950,802	2,972 Added 526.95%	3,536 $1.07 Million
Q1 2021 May 17, 2021	BUY	$268.3 - $380.31 $37,025 - $52,482	138 Added 32.39%	564 $155,000
Q4 2020 Feb 16, 2021	BUY	$248.13 - $308.36 $9,428 - $11,717	38 Added 9.79%	426 $125,000
Q3 2020 Nov 16, 2020	SELL	$215.51 - $272.51 $82,324 - $104,098	-382 Reduced 49.61%	388 $102,000
Q2 2020 Aug 13, 2020	SELL	$127.44 - $232.72 $46,005 - $84,011	-361 Reduced 31.92%	770 $173,000
Q1 2020 May 15, 2020	BUY	$108.83 - $165.23 $69,215 - $105,086	636 Added 128.48%	1,131 $149,000
Q4 2019 Feb 07, 2020	BUY	$106.59 - $164.21 $18,440 - $28,408	173 Added 53.73%	495 $79,000
Q3 2019 Nov 05, 2019	BUY	$113.31 - $150.51 $36,485 - $48,464	322 New	322 $37,000
Q2 2019 Aug 13, 2019	SELL	$115.0 - $141.58 $1,955 - $2,406	-17 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$98.85 - $134.59 $1,680 - $2,288	17 New	17 $2,000
Q3 2018 Nov 13, 2018	SELL	$75.5 - $96.63 $19,101 - $24,447	-253 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$74.84 - $100.16 $31,582 - $42,267	-422 Reduced 62.52%	253 $21,000
Q1 2018 May 15, 2018	BUY	$56.95 - $85.19 $38,441 - $57,503	675 New	675 $54,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Argenx Se Transaction History